Key updates to the Department of Justice Evaluation of Corporate Compliance Programs
The September 2024 update to the Department of Justice’s (DOJ) Evaluation of Corporate Compliance Programs (ECCP) gives firms much to contemplate and some pressing concerns to address, including the risks associated with emerging technologies.
Article
Managing the compliance risks of ephemeral messaging to meet DOJ guidance in healthcare and pharmaceuticals
Healthcare organizations and the pharmaceutical industry must look to implement solutions to ephemeral messaging in their compliance strategies.
Healthcare
Blog